Data / Form D filings / ApoVax, Inc.
ApoVax, Inc.: Form D filings
ApoVax, Inc., a pharmaceuticals company in Loisville, KY, filed 3 Form D notices with the SEC between 2011 and 2012. The latest, on November 26, 2012, reports $125,000 sold of a $500,000 offering to 1 investor.
Find out what ApoVax, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1044 EAST CHESTNUT ST, Loisville, KY, 40204
- Phone
- (502) 212-2493
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1329338
The full lists. Form D filings in Kentucky: 216 rows, $10.80, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 26, 2012 | New notice | $500,000 | $125,000 | $375,000 | 1 | Nov 13, 2012 | sec.gov |
| Dec 7, 2011 | New notice | $500,000 | $250,000 | $250,000 | 2 | Nov 28, 2011 | sec.gov |
| Jan 28, 2011 | New notice | $1,700,000 | $25,196 | $1,674,804 | 1 | Jan 18, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Haval J. Shirwan | Executive Officer, Director | |
| George R. Emont | Executive Officer, Director | |
| Michael J. Curtin | Director | |
| Steven R. Gailar | Executive Officer, Director |
Every Form D from the week of Nov 26, 2012 · All recent filings in Kentucky · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ApoVax, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.